| pubmed-article:12934974 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C0001807 | lld:lifeskim |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C0009079 | lld:lifeskim |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C0018546 | lld:lifeskim |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C0564567 | lld:lifeskim |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C0221765 | lld:lifeskim |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:12934974 | lifeskim:mentions | umls-concept:C0079809 | lld:lifeskim |
| pubmed-article:12934974 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:12934974 | pubmed:dateCreated | 2003-8-25 | lld:pubmed |
| pubmed-article:12934974 | pubmed:abstractText | The risk of suicide for schizophrenia patients is 20 to 50 times higher than that for the general population. Long-term treatment with clozapine, an atypical antipsychotic, has been shown to reduce the rate of suicide by 80% to 85%. The goal of the present study was to examine whether clozapine's effect on the reduction of suicidal behavior in chronic schizophrenic patients could be due to a reduction in impulsive-aggressive behavior. | lld:pubmed |
| pubmed-article:12934974 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12934974 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12934974 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12934974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12934974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12934974 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12934974 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12934974 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12934974 | pubmed:issn | 0160-6689 | lld:pubmed |
| pubmed-article:12934974 | pubmed:author | pubmed-author:SheitmanBrian... | lld:pubmed |
| pubmed-article:12934974 | pubmed:author | pubmed-author:WeizmanAbraha... | lld:pubmed |
| pubmed-article:12934974 | pubmed:author | pubmed-author:SpivakBaruchB | lld:pubmed |
| pubmed-article:12934974 | pubmed:author | pubmed-author:MesterRoberto... | lld:pubmed |
| pubmed-article:12934974 | pubmed:author | pubmed-author:ShabashEvgeny... | lld:pubmed |
| pubmed-article:12934974 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12934974 | pubmed:volume | 64 | lld:pubmed |
| pubmed-article:12934974 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12934974 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12934974 | pubmed:pagination | 755-60 | lld:pubmed |
| pubmed-article:12934974 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:meshHeading | pubmed-meshheading:12934974... | lld:pubmed |
| pubmed-article:12934974 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12934974 | pubmed:articleTitle | The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. | lld:pubmed |
| pubmed-article:12934974 | pubmed:affiliation | Clinical Research Unit, Ness Ziona Mental Health Center, Ness Ziona, Israel. baruchspivak@int.gov.il | lld:pubmed |
| pubmed-article:12934974 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12934974 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12934974 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12934974 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12934974 | lld:pubmed |
